ArriVent BioPharma, Inc. - Common Stock, $0.0001 par value (AVBP)

92 filings reported holding AVBP - ArriVent BioPharma, Inc. - Common Stock, $0.0001 par value as of Q4 2024.
ArriVent BioPharma, Inc. - Common Stock, $0.0001 par value (AVBP) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 28,465,885 shares of 40,225,592 outstanding shares and own 71% of the company stock.
Largest 10 shareholders include HHLR ADVISORS, LTD. (4,484,672 shares), ORBIMED ADVISORS LLC (3,027,328 shares), SUVRETTA CAPITAL MANAGEMENT, LLC (2,246,000 shares), BlackRock, Inc. (2,135,092 shares), FMR LLC (2,101,037 shares), Octagon Capital Advisors LP (2,059,387 shares), Sofinnova Investments, Inc. (1,696,752 shares), INFINITUM ASSET MANAGEMENT, LLC (1,643,923 shares), Novo Holdings A/S (1,520,627 shares), and General Catalyst Group Management, LLC (1,494,786 shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.